Raymond James Trust’s AllianceBernstein AB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$332K Sell
9,522
-24
-0.3% -$820 0.01% 981
2024
Q2
$323K Buy
9,546
+713
+8% +$23.9K 0.01% 942
2024
Q1
$307K Sell
8,833
-72
-0.8% -$2.39K 0.01% 964
2023
Q4
$276K Sell
8,905
-543
-6% -$16K 0.01% 968
2023
Q3
$287K Sell
9,448
-809
-8% -$25.7K 0.01% 882
2023
Q2
$330K Buy
10,257
+66
+0.6% +$2.26K 0.01% 845
2023
Q1
$373K Buy
10,191
+104
+1% +$3.92K 0.01% 762
2022
Q4
$347K Buy
10,087
+508
+5% +$18.8K 0.01% 766
2022
Q3
$336K Buy
9,579
+1,216
+15% +$51.4K 0.01% 739
2022
Q2
$348K Sell
8,363
-1,280
-13% -$53.8K 0.01% 731
2022
Q1
$453K Buy
9,643
+1,084
+13% +$50.4K 0.01% 675
2021
Q4
$418K Buy
8,559
+196
+2% +$10.2K 0.01% 730
2021
Q3
$415K Hold
8,363
0.01% 690
2021
Q2
$389K Buy
8,363
+2,089
+33% +$91K 0.01% 731
2021
Q1
$251K Sell
6,274
-493
-7% -$18.5K 0.01% 911
2020
Q4
$229K Buy
+6,767
New +$214K 0.01% 901

Other funds holding AB

Raymond James Trust's AB Position: Q3 2024 in Review

Raymond James Trust reduced its AllianceBernstein (AB) stake by 0.25% in Q3 2024, selling an estimated $820 and leaving 9,522 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #981.

Raymond James Trust first reported a position in AB in Q4 2020 and has held it in 16 quarters since. The position peaked at $453K in Q1 2022. 259 funds tracked by Wall St. Rank hold AB as of Q3 2024.

  • Raymond James Trust held 9,522 shares of AllianceBernstein worth $332K as of Q3 2024.
  • Raymond James Trust sold 24 AllianceBernstein shares in Q3 2024, an estimated $820.
  • AllianceBernstein made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #981 holding.
  • Raymond James Trust first reported a position in AllianceBernstein in Q4 2020 and has held it in 16 quarters since.
  • Raymond James Trust's AllianceBernstein position peaked at $453K in Q1 2022.
  • 259 funds tracked by Wall St. Rank held AllianceBernstein as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.